Local Anesthesia Drugs Market Size, Share & Trends Analysis Report By Product (Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine), By Application- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

The global Local Anesthesia Drugs market size was estimated at USD 2,658.70 million in 2021 and is expected to surpass around USD 7.40 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 5.68% during the forecast period 2022 to 2030.

Growth Factors:

There has been an increase in the number of surgical procedures performed across the globe, including dental procedures, cosmetic surgeries, and plastic surgeries. This is a major factor driving the market for local anesthetics. A key trend observed in the market is a significant rise in demand for post-operative pain relief options, on the heels of an increasing number of surgical procedures. This trend is likely to continue throughout the forecast period, positively influencing the demand for local anesthesia drugs. An approximate 65.0% of the total surgical procedures performed need postoperative pain management.

Growth in the number of surgeries performed can be attributed to the aging population, a demographic group that is more prone to chronic diseases such as cardiovascular disorders, respiratory ailments, cancer, neurological disorders, and other gastro, orthopedic, and spinal problems. Advancements in drug delivery technologies are also expected to contribute to the demand for local anesthetics in surgical procedures. For instance, DepoFoam technology uses a new method to deliver bupivacaine and is very efficient in the management of post-operative pain.

The growth of the market for local anesthesia drugs is also fueled by the introduction of new and effective drugs such as articaine, levobupivacaine, and ropivacaine. This growth is supplemented by increasing healthcare expenditure in developing countries such as India, China, and Brazil, where the number of surgeries performed has been on a steady rise.

Report Scope of the Local Anesthesia Drugs Market

Local Anesthesia Drugs Market Trends

Various factors such as the rising number of surgeries, new anesthetic medication approvals, and the expanded use of local anesthetics in post-operative pain are driving the expansion for local anesthesia pharmaceuticals market. Moreover,the anesthetic medications are primarily used during surgical operations. As a result, the local anesthesia market is expected to grow substantially owing to its significance during crucial surgeries

The demand for local anesthesia in the industry is fueled by several factors. Within the projected period, the global-local anesthesia pharmaceuticals market is expected to grow due to an increase in the surgical cases and advancements in drug delivery, such as computer-based local anesthetic delivery and vibrotactile devices.

However, the market is projected to be constrained by the negative effects of these treatments and a stringent regulatory framework. Some significant medication side effects, such as CNS toxicity, respiratory depression and cardiovascular toxicity are among the significant reasons holding back the worldwide local anesthetic pharmaceuticals market from reaching its full potential.

Product Insights

On the basis of product, the local anesthesia drugs market has been segmented into bupivacaine, ropivacaine, lidocaine, chloroprocaine, prilocaine, benzocaine, and other local anesthetics. The lidocaine drug dominated the market in 2021 owing to its extensive use as a topical and injectable anesthetic. The entry of newer drugs such as articaine and bupivacaine will, however, threaten to challenge the market share of this drug over the forecast period.

Bupivacaine is expected to witness the fastest growth through 2030 due to a significant number of clinical trials conducted on the drug as of 2021. The growth is also attributed to its extensive use in postoperative pain management. Drugs such as ropivacaine and articaine are also expected to witness promising growth over the forecast period.

Application Insights

In terms of application, the market for local anesthesia drugs has been bifurcated into injectable and surface anesthetics. By way of revenue, the injectable anesthetics segment dominated the market and this trend is likely to continue during the forecast period. This is primarily attributed to the extensive usage of injectable anesthetics in different surgical procedures. Surface anesthetics, on the other hand, are anticipated to witness the fastest growth over the forecast period. Advancements in drug delivery systems are expected to be the key driving factor for this segment.

Regional Insights

North America held the largest share in the market owing to a significant number of surgical procedures performed in the U.S. The country accounts for more than 30.9% of surgical procedures performed across the globe. High per capita income, improved access to healthcare, an increase in the prevalence of chronic diseases, and rising geriatric population are driving the market for local anesthesia drugs in this region.

Europe held the second-largest share as of 2021 and is expected to witness decent growth during the forecast period. The growth is attributed to the increasing volume of dental and cosmetic surgeries, advancements in surgical procedures, and growing use of local anesthetics in post-operative pain management.

The Asia Pacific and Latin American markets are expected to exhibit lucrative growth over the forecast period owing to expanding geriatric population, which is anticipated to drive the number of surgical procedures performed in the region. The decline in opioid use in the region is also expected to contribute to market growth.

Recent Developments

• In March, 2021, Pacira BioSciences Inc.'s introduced supplemental new drug application (sNDA) for the augmented use of Exparel (Bupivacaine Liposome Injectable Suspension) in pediatric patients that was approved by the U.S. Food and Drug Administration (FDA).
• In December 2021, Hikma Pharmaceuticals PLC (Hikma) introduced Bupivacaine HCl Injection USP through its U.S. subsidiary Hikma Pharmaceuticals USA Inc. In 10 ml and 30 ml doses.

Some of the prominent players in the Local Anesthesia Drugs Market include:  Aspen Pharmacare; Fresenius Kabi; Novartis, Inc.; Sagent Pharmaceutical; Pacira Pharmaceutical; Mylan; Teva Pharmaceuticals.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Local Anesthesia Drugs market

• Product

• Bupivacaine
• Ropivacaine
• Lidocaine
• Chloroprocaine
• Prilocaine
• Benzocaine
• Other local anesthetics
• Application
• Injectable
• Surface Anesthetic

By Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa

Key Points Covered in Local Anesthesia Drugs Market Study:

• Growth of Local Anesthesia Drugs in 2022
• Market Estimates and Forecasts (2017-2030)
•  Brand Share and Market Share Analysis
•  Key Drivers and Restraints Shaping Market Growth
•  Segment-wise, Country-wise, and Region-wise Analysis
•  Competition Mapping and Benchmarking
•  Recommendation on Key Winning Strategies
•  COVID-19 Impact on Demand for Local Anesthesia Drugs and How to Navigate
•  Key Product Innovations and Regulatory Climate
•  Local Anesthesia Drugs Consumption Analysis
•  Local Anesthesia Drugs Production Analysis
•  Local Anesthesia Drugs and Management